FR

Dominique Costantini

 

Average Co-Inventor Count = 1.0


Loading Chart...

Title: Innovations by Dominique Costantini

Introduction

Dominique Costantini is a notable inventor based in France. He has made significant contributions to the field of pharmaceutical innovations, particularly in the treatment of viral infections. His work focuses on developing advanced drug delivery systems that enhance the efficacy of antiviral agents.

Latest Patents

Costantini's latest patents include "Mucoadhesive Buccal Tablets For The Treatment Of Orofacial Herpes." This invention relates to the treatment and/or prevention of muco-cutaneous herpes simplex virus diseases using prolonged release mucoadhesive buccal tablets comprising an acyclic guanosine antiviral agent. These tablets are particularly suitable for the treatment and/or prevention of orofacial herpes. Another significant patent is "Mucosal Bioadhesive Slow Release Carrier For Delivering Active Principles." This mucosal bioadhesive slow release carrier comprises an active principle and is devoid of starch and lactose, allowing it to release the active principal for a duration of longer than 20 hours. This bioadhesive carrier contains a diluent, an alkali metal alkylsulfate, a binding agent, at least one bioadhesive polymer, and at least one sustained release polymer, along with a method for its preparation.

Career Highlights

Throughout his career, Costantini has worked with various companies, including Epi Health, LLC and Lnhc, Inc. His experience in these organizations has allowed him to refine his skills in pharmaceutical development and innovation.

Collaborations

Costantini has collaborated with several professionals in his field, including his coworker Pierre Attali. These collaborations have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Dominique Costantini is a dedicated inventor whose work in pharmaceutical innovations has the potential to significantly impact the treatment of viral infections. His contributions to drug delivery systems demonstrate his commitment to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…